October 23, 2026 09:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tiger Shroff, not Salman Khan, was the main target, probe reveals shocking details | Dammam airport attack: Indian killed, two compatriots injured as Saudi Arabia faces fresh strikes | ‘Among others’: Macron takes swipe at Trump over France unrest, calls foreign leaders’ remarks ‘stupid’ | ‘Specific threat-related inputs’: Delhi Police blocks Diljit Dosanjh’s Delhi concert | ‘Barbaad kare alfaz mere’: Ranbir Kapoor apologises for Dussehra gaffe in Kolkata | Delhi court releases CJP's Saurav Das and Ashutosh Ranka after 7 days in custody | ‘We are seeing what is happening outside our country’: Delhi HC judge’s remark as CJP leaders Saurav Das and Ashutosh Ranka withdraw custody plea | Salman Khan was the original target? Tiger Shroff firing probe reveals shocking twist | ‘UN experts are an oxymoron’: Marco Rubio takes swipe at UN, refuses to comment on India's protests | ‘US ties with no country come at India's expense’: Marco Rubio addresses concerns over Pakistan, China
Canada
Image credit: Wikimedia Commons

Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant

| @indiablooms | Sep 03, 2022, at 05:03 am

Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.

This vaccine has been approved for use in adults and will become the first COVID-19 vaccine available in Canada that targets Omicron in addition to the original strain of the coronavirus.

Health Canada said in a decision summary made public Thursday, that the new vaccine shows “significantly higher responses” to the Omicron BA.1 virus in comparison to Moderna’s original coronavirus vaccine, officially branded as Spikevax.

Although the updated vaccine was developed to target the Omicron BA.1 variant, clinical trials, says Health Canada suggest the new vaccine still shows a stronger immune response against the more recent mutations of Omicron — BA.4 and BA.5 — which are now dominant.

According to recommendations of the National Advisory Committee on Immunization (NACI) the updated vaccine should be offered to adults who are recommended to receive a fall booster dose.

NACI says that the vaccine could also be offered to adolescents between 12 and 17 with “moderately to severely immunocompromising conditions” and those who have elevated social risk factors.

(Reporting by Asha Bajaj)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.